Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Seattle Genetics, on the Verge of Going Commercial, Seeks to Keep Its Scientific Soul
Motley Fool
Tuesday, July 5, 2011 - 11:29am
tags:
Seattle Genetics
Eight years in the making, N.J.-based Merck developing new kind of insomnia drug
Newark Star-Ledger, NJ
Tuesday, July 5, 2011 - 11:28am
tags:
Merck, insomnia
Merck commits to increased transparency on study protocols
Pharma Times, UK
Tuesday, July 5, 2011 - 11:21am
tags:
Merck, transparency, clinical trials
A Link Between Antidepressants And Autism?
Pharmalot
Tuesday, July 5, 2011 - 11:20am
tags:
autism, SSRIs, antidepressants, pregnancy
Pfizer Stock Rises Despite Concerns About Stop-Smoking Drug
Barron's
Tuesday, July 5, 2011 - 10:57am
tags:
Pfizer, Chantix, smoking cessation
Par Restructures Branded Business
Yahoo/Zacks.com
Tuesday, July 5, 2011 - 10:56am
tags:
Par Pharmaceutical, reorganization, AstraZeneca
GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
Yahoo
Tuesday, July 5, 2011 - 10:54am
tags:
GSK, drug reps, compensation
Novartis to File Drug for Breast Cancer
WSJ Online
Tuesday, July 5, 2011 - 10:05am
tags:
Novartis, breast cancer, Afinitor
July Catalysts for Biotech and Drug Stocks
Minyanville
Tuesday, July 5, 2011 - 9:58am
tags:
Seattle Genetics, Bristol-Myers Squibb, JNJ, advisory panels, FDA, Transcept, AstraZeneca, GSK, Human Genome Sciences, Merck, Theravance, Amgen, Biogen Idec, Acorda Therapeutics
Titan Pharmaceuticals Is Back in Play With FDA Questions Resolved
Seeking Alpha
Tuesday, July 5, 2011 - 9:55am
tags:
FDA, Titan, Novartis, Vanda, Probuphine
Generics advancing on lucrative pet drug market
Yahoo/AP
Tuesday, July 5, 2011 - 9:54am
tags:
generics, animal health
Pfizer's Chantix Weighed by FDA After 72% Added Heart Risk
Bloomberg
Tuesday, July 5, 2011 - 9:53am
tags:
smoking cessation, Pfizer, Chantix, FDA
Justices rule for drugmakers in 2 high-profile cases
amednews.com
Monday, July 4, 2011 - 9:30am
tags:
Supreme Court, generics, prescription data
SIGA Shorts Create a Buying Opportunity
Seeking Alpha
Monday, July 4, 2011 - 9:26am
tags:
SIGA technologies
Two High Yield Pharmaceutical Stocks to Buy and Hold for the Next Decade
Seeking Alpha
Monday, July 4, 2011 - 9:24am
tags:
Abbott Laboratories, Novartis
Teva Markets its Generic Version of Lipitor in U.K., FT Reports
Bloomberg
Monday, July 4, 2011 - 9:23am
tags:
generics, UK, Lipitor, statins, Teva Pharmaceuticals, Pfizer
J&J-Bayer’s Xarelto Wins U.S. Approval for Hip Surgery Use
Bloomberg
Monday, July 4, 2011 - 9:21am
tags:
Bayer, JNJ, Xarelto
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Monday, July 4, 2011 - 9:20am
tags:
Dendreon, prostate cancer, cancer immunotherapy, Cel-Sci, Cell Therapeutics, ImmunoCellular, Keryx, Teva Pharmaceuticals, Oncothyreon
Questcor hits 52-week high
Marketwatch
Monday, July 4, 2011 - 9:18am
tags:
Questcor Pharmaceuticals, MS, multiple sclerosis, Acthar
Jazz Drug Helps Keep Narcolepsy Sufferers Awake
Investors.com
Monday, July 4, 2011 - 9:15am
tags:
Jazz Pharmaceuticals, narcolepsy, Xyrem

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.